IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
Clinical trial NCT05994131 · RECRUITING
Trial details
- NCT number
- NCT05994131
- Sponsor
- InxMed (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-13
- Primary completion
- 2026-07-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.